These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 23651793)
21. Comparative pharmacokinetics and pharmacodynamics of a PEGylated recombinant human growth hormone and daily recombinant human growth hormone in growth hormone-deficient children. Hou L; Chen ZH; Liu D; Cheng YG; Luo XP Drug Des Devel Ther; 2016; 10():13-21. PubMed ID: 26719670 [TBL] [Abstract][Full Text] [Related]
22. Bioequivalence of generic and branded subcutaneous enoxaparin: a single-dose, randomized-sequence, open-label, two-period crossover study in healthy Chinese male subjects. Feng L; Shen-Tu J; Liu J; Chen J; Wu L; Huang M Clin Ther; 2009 Jul; 31(7):1559-67. PubMed ID: 19695405 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics and pharmacodynamics of a new formulation of recombinant human growth hormone administered by ZomaJet 2 Vision, a new needle-free device, compared to subcutaneous administration using a conventional syringe. Agersø H; Møller-Pedersen J; Cappi S; Thomann P; Jesussek B; Senderovitz T J Clin Pharmacol; 2002 Nov; 42(11):1262-8. PubMed ID: 12412826 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics and bioequivalence of two formulations of rebamipide 100-mg tablets: a randomized, single-dose, two-period, two-sequence crossover study in healthy Korean male volunteers. Cho HY; Yoon H; Park GK; Lee YB Clin Ther; 2009 Nov; 31(11):2712-21. PubMed ID: 20110013 [TBL] [Abstract][Full Text] [Related]
25. Comparative bioavailability study of triflusal oral solution vs. triflusal capsules in healthy subjects. A single, randomized, two-way cross-over, open-label phase I study. Izquierdo I; Borja J; Rovira S; Pelagio P; Torres F; Cebrecos J; García-Rafanell J Arzneimittelforschung; 2010; 60(1):36-41. PubMed ID: 20184225 [TBL] [Abstract][Full Text] [Related]
26. Relative bioavailability of tizanidine hydrochloride capsule formulation compared with capsule contents administered in applesauce: a single-dose, open-label, randomized, two-way, crossover study in fasted healthy adult subjects. Henney HR; Fitzpatrick A; Stewart J; Runyan JD Clin Ther; 2008 Dec; 30(12):2263-71. PubMed ID: 19167586 [TBL] [Abstract][Full Text] [Related]
27. Tolerability and pharmacokinetic properties of ondansetron administered subcutaneously with recombinant human hyaluronidase in minipigs and healthy volunteers. Dychter SS; Harrigan R; Bahn JD; Printz MA; Sugarman BJ; DeNoia E; Haughey DB; Fellows D; Maneval DC Clin Ther; 2014 Feb; 36(2):211-24. PubMed ID: 24486335 [TBL] [Abstract][Full Text] [Related]
28. A reversible albumin-binding growth hormone derivative is well tolerated and possesses a potential once-weekly treatment profile. Rasmussen MH; Olsen MW; Alifrangis L; Klim S; Suntum M J Clin Endocrinol Metab; 2014 Oct; 99(10):E1819-29. PubMed ID: 25013997 [TBL] [Abstract][Full Text] [Related]
29. Subcutaneous Bioavailability of Taspoglutide at 3 Different Injection Sites in Healthy Overweight/Obese Subjects. Sturm-Pellanda C; Abt M; Sanwald-Ducray P; Schmitt C Clin Ther; 2015 Nov; 37(11):2439-48. PubMed ID: 26412802 [TBL] [Abstract][Full Text] [Related]
30. Relative bioavailability of a newly developed 5-mg levomethadone hydrochloride IR tablet (L-Polamidon® 5 mg tablets) in comparison with the 5-mg levomethadone hydrochloride oral solution (L-Polamidon® solution for substitution) as reference product. Blume HH; Wedemeyer RS; Donath F; Roscher K; Elvert G; Wagner D; Bley O; Vuia A; Todorova-Sanjari M; Villalobos R; Schug B Int J Clin Pharmacol Ther; 2015 Apr; 53(4):335-44. PubMed ID: 25669614 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers. Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017 [TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic, tolerability, and bioequivalence comparison of three different intravenous formulations of recombinant human erythropoietin in healthy Korean adult male volunteers: an open-label, randomized-sequence, three-treatment, three-way crossover study. Cho SH; Lim HS; Ghim JL; Choe S; Kim UJ; Jung JA; Bae KS Clin Ther; 2009 May; 31(5):1046-53. PubMed ID: 19539105 [TBL] [Abstract][Full Text] [Related]
33. Clinical pharmacodynamic effects of the growth hormone receptor antagonist pegvisomant: implications for cancer therapy. Yin D; Vreeland F; Schaaf LJ; Millham R; Duncan BA; Sharma A Clin Cancer Res; 2007 Feb; 13(3):1000-9. PubMed ID: 17289896 [TBL] [Abstract][Full Text] [Related]
34. Comparison of fasting bioavailability among 100-mg commercial, 100-mg generic, and 50-mg chewable generic sildenafil tablets in healthy male Mexican volunteers: a single-dose, 3-period, crossover study. Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; García-González A; Ramírez-San Juan E Clin Ther; 2012 Mar; 34(3):689-98. PubMed ID: 22386826 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers. Lal R; Sukbuntherng J; Luo W; Chen D; Vu A; Tovera J; Cundy KC Clin Ther; 2009 Aug; 31(8):1776-86. PubMed ID: 19808136 [TBL] [Abstract][Full Text] [Related]
36. Randomized, crossover, single-blind, placebo-controlled, human pharmacology clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: multiple-dose pharmacokinetics. Algorta J; Pena MA; Alvarez A; Maraschiello C; Maruhn D; Windisch M; Mucke HA Int J Clin Pharmacol Ther; 2009 Jul; 47(7):483-90. PubMed ID: 19640356 [TBL] [Abstract][Full Text] [Related]
37. Safety, tolerability, and pharmacokinetics of a single ascending dose of baicalein chewable tablets in healthy subjects. Li M; Shi A; Pang H; Xue W; Li Y; Cao G; Yan B; Dong F; Li K; Xiao W; He G; Du G; Hu X J Ethnopharmacol; 2014 Oct; 156():210-5. PubMed ID: 25219601 [TBL] [Abstract][Full Text] [Related]
38. Long-term safety of pegvisomant in patients with acromegaly: comprehensive review of 1288 subjects in ACROSTUDY. van der Lely AJ; Biller BM; Brue T; Buchfelder M; Ghigo E; Gomez R; Hey-Hadavi J; Lundgren F; Rajicic N; Strasburger CJ; Webb SM; Koltowska-Häggström M J Clin Endocrinol Metab; 2012 May; 97(5):1589-97. PubMed ID: 22362824 [TBL] [Abstract][Full Text] [Related]
39. Bioequivalence of two subcutaneous pharmaceutical products of interferon beta la. Di Girolamo G; Kauffman MA; González E; Papouchado M; Ramírez A; Keller G; Carbonetto C; Dabsys S; Vidal A; Sterin-Prync A; Diez RA Arzneimittelforschung; 2008; 58(4):193-8. PubMed ID: 18540482 [TBL] [Abstract][Full Text] [Related]
40. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study. Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]